Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Nie (Portland, United States of America), D. Jacoby (Portland, United States of America), A. Fryer (Portland, United States of America). Pioglitazone inhibits obesity-related airway hyperreactivity. 2904

Member's Comments

No comment yet.

Related content which might interest you: HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice Source: Eur Respir J 2008; 32: 970-978 Year: 2008 Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Effect of pinacidil, a KATPCO, on airway hyperresponsiveness and remodeling in guinea-pigs with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 80s Year: 2004 Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Inhaled doxycycline reduces allergen-induced airway inflammation, hyperresponsiveness and remodelling in mice Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005 The role of CCR5 in allergen-induced airway hyperresponsiveness and airway inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Inhaled insulin does not trigger lung inflammation and airway remodelling Source: Eur Respir J 2009; 33: 444-445 Year: 2009 The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 433s Year: 2006 Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion Source: ERJ Open Res, 7 (1) 00394-2020; 10.1183/23120541.00394-2020 Year: 2021 Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 Antioxidant, γ-glutamylcysteinylethyl ester, ameliorates airway hyperresponsiveness in a mouse asthma model Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006 Adiposity, asthma and airway inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 235s Year: 2006 Oral presentation: ILC2 contribute to ozone-induced airway hyperresponsiveness in obese mice Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001 Hepatocyte growth factor attenuates airway hyperresponsiveness and airway inflammation in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 27s Year: 2002